Assembly Biosciences, Inc.
Price Action
Technical Summary
CONSOLIDATINGAssembly Biosciences, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is weak (RS Rating: 35), showing significant lag compared to the market leaders. Earnings growth of 245% provides fundamental context to the price action. Investors should exercise caution due to high volatility (63% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $28.49 | +8.55% | ABOVE |
| 50 SMA | $28.61 | +8.11% | ABOVE |
| 100 SMA | $29.26 | +5.72% | ABOVE |
| 150 SMA | $30.15 | +2.60% | ABOVE |
| 200 SMA | $28.36 | +9.04% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is ASMB in an uptrend right now?
ASMB has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is ASMB overbought or oversold?
ASMB's RSI (14) is 65. The stock is in neutral territory, neither overbought nor oversold.
Is ASMB outperforming the market?
ASMB has a Relative Strength (RS) Rating of 35 out of 99. ASMB is currently lagging the broader market.
Where is ASMB in its 52-week range?
ASMB is trading at $30.93, which is 78% of its 52-week high ($39.71) and 69% above its 52-week low ($11.64).
How volatile is ASMB?
ASMB has a Beta of 1.67 and 52-week volatility of 63%. It's more volatile than the S&P 500 - expect bigger swings.